Celik, Alan, et al. “Capecitabine Monotherapy As First-Line Treatment in Advanced HER2-Normal Breast Cancer – a Nationwide, Retrospective Study”. Acta Oncologica, vol. 63, no. 1, June 2024, pp. 494-02, doi:10.2340/1651-226X.2024.38886.